Xinshang Capital
新尚资本
Xinshang Capital (新尚资本) is an investment fund that appears primarily as a co-investor or follow-on investor in early-stage venture deals. The fund has participated in the angel round of Yitu Technology (弋途科技) alongside Yunqi Capital, Jishi Capital, and others , and joined the Pre-A and subsequent rounds of Qiheshengke Biotechnology (齐禾生科), a Suzhou-based gene-editing firm, alongside Gaorong Capital, Source Code Capital, and Zhongxin Capital . It also appears as an LP in ChaoXi Capital's fundraising, listed alongside industrial groups such as JA Solar's controlling shareholder Jingtaifu, as well as various market-oriented fund-of-funds and state-owned investment platforms . The corpus does not contain a direct profile of Xinshang Capital's own founding, team, or assets under management; its characteristics must be inferred from these disclosed positions.
AI-generated — may contain errors, please verify.
Coverage
BlueRun Ventures Leads Rounds, Automotive Communication Chip Firm Lingpao Microelectronics Closes Two Consecutive Rounds Exceeding RMB 100 Million in Total | BlueRun Ventures
a domestic leader in Bluetooth high-precision positioning chips
"Yitu Technology" Raises Tens of Millions in Angel Round Led by Yunqi Capital | Yunxun
Providing middleware solutions for the intelligent transformation of Chinese auto brands
A Fund Moving Against the Tide, Riding the Pulse of the Era丨Entering the Game
Please keep welcoming the "heretical."
Code Moment | "Singularity Energy" Closes Over RMB 700 Million Series B Round, Source Code Capital Continues to Double Down
JD Energy will continue to contribute its share of strength to the healthy, high-quality development of the energy storage industry and to the realization of China's dual-carbon goals!
Chip/Consumer Electronics/Gene Editing Firms Raise New Funding; Quantum Computers, Micro-Display Chips Achieve Global Leadership | Rongbao · April
Targeting international advanced standards.
Qihe Biotech Closes Over 100 Million Yuan Pre-A Round to Accelerate Development and Application of Novel Gene-Editing Technologies
Accelerate the commercialization of gene-edited breeding.
